Inspire Medical Systems Inc $ 232.79 6.55 (2.9%)
Volume:
353,338
Avg Vol (1m):
234,562
Market Cap $:
6.32 Bil
Enterprise Value $:
6.11 Bil
PE Ratio:
0.00
PB Ratio:
27.35
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 7.65 | ||
| Equity-to-Asset | 0.82 | ||
| Debt-to-Equity | 0.13 | ||
| Debt-to-EBITDA | -0.57 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 73.31 | ||
| Beneish M-Score | -2.13 | ||
| WACC vs ROIC | |||
Profitability Rank | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -48.72 | ||
| Net Margin % | -49.58 | ||
| ROE % | -29.81 | ||
| ROA % | -24.42 | ||
| ROC (Joel Greenblatt) % | -345.34 | ||
| 3-Year Revenue Growth Rate | 27.9 | ||
| 3-Year EBITDA Growth Rate | -21.9 | ||
| 3-Year EPS without NRI Growth Rate | -15.8 |
INSP
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 27.35 | ||
| PS Ratio | 53.06 | ||
| EV-to-EBIT | -111.18 | ||
| EV-to-EBITDA | -112.9 | ||
| EV-to-Revenue | 52.97 | ||
| Current Ratio | 13.02 | ||
| Quick Ratio | 12.61 | ||
| Days Inventory | 167.72 | ||
| Days Sales Outstanding | 79.29 | ||
| Days Payable | 149.31 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.6 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 27.35 | ||
| Earnings Yield (Greenblatt) % | -0.9 |